Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 57 resultados

LEAPS: Integrating Multi-Disciplinary Expertise in a Learning and Adaptive European Pandemic Preparedness S... STATENS SERUM INSTITUT participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-07 The COVID-19 pandemic has exposed a global need for accelerating research, improving surveillance, and efficiently developing countermeasure...
2023-10-09 - 2027-09-30 | Financiado

REACT: Respiratory Host-Pathogen Interaction STATENS SERUM INSTITUT tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Lower respiratory tract infections resulting from seasonal epidemics and pandemics are among the leading causes of death globally. There is...
2022-08-01 - 2026-07-31 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research STATENS SERUM INSTITUT participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

PROMISE: Preparing for RSV Immunisation and Surveillance in Europe STATENS SERUM INSTITUT participó en un H2020: H2020-JTI-IMI2-2020-22-single-stage RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progre...
2021-05-21 - 2024-04-30 | Financiado

SUPPORT-E: SUPporting high quality evaluation of COVID 19 convalescent Plasma thrOughoutT Europe STATENS SERUM INSTITUT participó en un H2020: Coronavirus disease 19 (COVID-19) is provoking the greatest global health crisis of this generation. With no vaccine or specific antiviral t...
2020-09-02 - 2025-12-31 | Financiado

TRANSVAC-DS: DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE STATENS SERUM INSTITUT participó en un H2020: H2020-SC5-2018-2019-2020 The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishme...
2020-06-09 - 2023-02-28 | Financiado

CORONADX: Three Rapid Diagnostic tests Point of Care for COVID 19 CoronaThree Rapid Diagnostic tests Point... STATENS SERUM INSTITUT participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 On 30th January 2020 WHO declared a global health emergency for the outbreak of the 2019 novel Coronavirus (COVID-19, or 2019-nCoV) that ori...
2020-04-08 - 2023-09-30 | Financiado

CoroNAb: Nanobodies and antibodies against 2019 nCoV STATENS SERUM INSTITUT participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 Overview: As of Feb 12th, 2020, the death toll of the 2019-nCoV (COVID-19) epidemic has surpassed 1000, rapidly eclipsing the total mortalit...
2020-04-06 - 2022-09-30 | Financiado

FAIR: FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG RESISTA... STATENS SERUM INSTITUT participó en un H2020: H2020-SC1-BHC-2018-2020 Bacterial pneumonia is a leading cause of morbidity and mortality worldwide. Antibiotics constitute the standard of care but are faced with...
2019-12-06 - 2025-06-30 | Financiado

HEAP: Human Exposome Assessment Platform STATENS SERUM INSTITUT participó en un H2020: H2020-SC1-BHC-2018-2020 HEAP will provide a research resource for the integrated and efficient analysis of the human exposome. One primary outcome of the project is...
2019-12-06 - 2024-12-31 | Financiado

COMBINE: Collaboration for Prevention and Treatment of MDR Bacterial Infections STATENS SERUM INSTITUT participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The loss of antibiotic effectiveness due to increasing antimicrobial resistance (AMR) is a serious threat to global public health. The IMI2...
2019-11-27 - 2025-10-31 | Financiado

PAVE: A nanovaccine Approach for the treatment of Pancreatic Cancer STATENS SERUM INSTITUT participó en un H2020: H2020-MSCA-ITN-2019 A Nanovaccine Approach For The Treatment of Pancreatic Cancer By Multicomponent Immuno-Modulation: Pancreatic ductal adenocarcinoma (PDAC) i...
2019-09-12 - 2024-03-31 | Financiado

VITAL: Vaccines and Infectious Diseases in the Ageing PopuLation STATENS SERUM INSTITUT participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage Today’s major challenge is to improve efficacy of vaccines to protect the growing ageing population against infectious diseases (ID). The VI...
2018-12-10 - 2024-12-31 | Financiado

VacPath: Novel vaccine vectors to resist pathogen challenge STATENS SERUM INSTITUT participó en un H2020: H2020-MSCA-ITN-2018 Infectious diseases are a major burden and constant threat to European populations and economies. While barely perceived as a danger not too...
2018-08-30 - 2024-10-31 | Financiado

CHIPS: Effects of Prenatal Exposure to Acrylamide on Health Prospective Biomarker Based Studies STATENS SERUM INSTITUT participó en un H2020: ERC-2017-STG Background: Acrylamide is a chemical formed in many commonly consumed foods and beverages. It is neurotoxic, crosses the placenta and has be...
2017-11-29 - 2025-06-30 | Financiado

One Health EJP: Promoting One Health in Europe through joint actions on foodborne zoonoses antimicrobial resistance... STATENS SERUM INSTITUT participó en un H2020: H2020-SFS-2016-2017 The One Health concept recognizes that the human health is tightly connected to the health of animals and the environment, i.e. that animal...
2017-10-09 - 2023-09-30 | Financiado

CARTNET: Combatting Antimicrobial Resistance Training Network STATENS SERUM INSTITUT participó en un H2020: H2020-MSCA-ITN-2017 CARTNET trains young researchers in Europe to address serious and global problems of antibiotic resistance. Disease-causing bacteria are bec...
2017-08-31 - 2021-12-31 | Financiado

TRANSVAC2: European Vaccine Research and Development Infrastructure STATENS SERUM INSTITUT participó en un H2020: H2020-INFRAIA-2016-2017 TRANSVAC2 is the follow-up project to its successful predecessor project TRANSVAC, the European Network of Vaccine Research and Development...
2017-07-28 - 2023-04-30 | Financiado

TracVac: Developing a Chlamydia Trachomatis vaccine STATENS SERUM INSTITUT tramitó un H2020: H2020-SC1-2016-2017 The TRACVAC Consortium will eliminate the global problem of blinding trachoma through the development of a vaccine. Our strategy of the proj...
2017-02-22 - 2022-02-28 | Financiado

SSI